Literature DB >> 10758272

Agelotoxin: a phospholipase A(2) from the venom of the neotropical social wasp cassununga (Agelaia pallipes pallipes) (Hymenoptera-Vespidae).

H Costa1, M S Palma.   

Abstract

The neotropical wasp Agelaia pallipes pallipes is aggressive and endemic in southeast of Brazil, where very often it causes stinging accidents in rural areas. By using gel filtration on Sephadex G-100, followed by high performance reversed phase chromatography in a C-18 column under acetonitrile/water gradient, the agelotoxin was purified: a toxin presenting phospholipase A(2) (PLA(2)) activity, which occurs under equilibrium of three different aggregation states: monomer (mol. wt 14 kDa), trimer (mol. wt 42 kDa) and pentamer (mol. wt 74 kDa). The enzyme presents high sugar contents attached to the protein chain (22% [w/w]) and a transition of the values of pH optimum for the substrate hydrolysis from 7.5 to 9.0, under aggregation from monomer to pentamer. All the aggregation states present Michaelian steady-state kinetic behavior and the monomer polymerization caused a decreasing of phospholipasic activity due a non-competitive inhibition promoted by the formation of a quaternary structure. The PLA(2) catalytic activity of agelotoxin changes according to its state of aggregation (from 833 to 12533 micromol mg(-1) min(-1)) and both the monomeric and oligomeric forms present lowest activities than the PLA(2) from Apis mellifera venom and hornetin from Vespa basalis. Agelotoxin is also a very potent direct hemolysin; the monomer of agelotoxin presented hemolytic actions until 200 times higher than the PbTx from P. paulista, 740 times higher than the PLA(2) from A. mellifera, 570 times higher than that of neutral PLA(2) from N. nigricolis and about 1250 times than that of cardiotoxin from Naja naja atra venom.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758272     DOI: 10.1016/s0041-0101(99)00199-3

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  5 in total

1.  Bee venom processes human skin lipids for presentation by CD1a.

Authors:  Elvire A Bourgeois; Sumithra Subramaniam; Tan-Yun Cheng; Annemieke De Jong; Emilie Layre; Dalam Ly; Maryam Salimi; Annaliza Legaspi; Robert L Modlin; Mariolina Salio; Vincenzo Cerundolo; D Branch Moody; Graham Ogg
Journal:  J Exp Med       Date:  2015-01-12       Impact factor: 14.307

2.  Biochemical characterization of a phospholipase A2 homologue from the venom of the social wasp Polybia occidentalis.

Authors:  Rafaela Diniz-Sousa; Anderson M Kayano; Cleópatra A Caldeira; Rodrigo Simões-Silva; Marta C Monteiro; Leandro S Moreira-Dill; Fernando P Grabner; Leonardo A Calderon; Juliana P Zuliani; Rodrigo G Stábeli; Andreimar M Soares
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-02-15

3.  Virucidal activity of oriental hornet Vespa orientalis venom against hepatitis C virus.

Authors:  Moustafa Sarhan; Alaa M H El-Bitar; Amaal Mohammadein; Mohammed Elshehaby; Hak Hotta
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-11-19

Review 4.  Mastoparans: A Group of Multifunctional α-Helical Peptides With Promising Therapeutic Properties.

Authors:  Carlos José Correia de Santana; Osmindo Rodrigues Pires Júnior; Wagner Fontes; Mário Sérgio Palma; Mariana S Castro
Journal:  Front Mol Biosci       Date:  2022-06-24

Review 5.  Current Advances in Immunological Studies on the Vespidae Venom Antigen 5: Therapeutic and Prophylaxis to Hypersensitivity Responses.

Authors:  Murilo Luiz Bazon; Lais Helena Silveira; Patricia Ucelli Simioni; Márcia Regina Brochetto-Braga
Journal:  Toxins (Basel)       Date:  2018-07-24       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.